[go: up one dir, main page]

US1381295A - Process for the manufacture of metal pyrophosphate casein compounds colloidally soluble in dilute alkaline solutions - Google Patents

Process for the manufacture of metal pyrophosphate casein compounds colloidally soluble in dilute alkaline solutions Download PDF

Info

Publication number
US1381295A
US1381295A US367465A US36746520A US1381295A US 1381295 A US1381295 A US 1381295A US 367465 A US367465 A US 367465A US 36746520 A US36746520 A US 36746520A US 1381295 A US1381295 A US 1381295A
Authority
US
United States
Prior art keywords
manufacture
casein
alkaline solutions
dilute alkaline
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US367465A
Inventor
Frey Albert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoffmann La Roche Inc
Original Assignee
Hoffmann La Roche Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche Inc filed Critical Hoffmann La Roche Inc
Priority to US367465A priority Critical patent/US1381295A/en
Application granted granted Critical
Publication of US1381295A publication Critical patent/US1381295A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732Casein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Definitions

  • U I E y invention relates to a new process for the manufacture of metal pyrophosphate casein compounds colloidally soluble in dilute alkaline solutions, which consists in dis solving casein in alkali pyrophosphate and adding another metal salt to this solution.
  • Compounds which contain albumin, phosphoric acid and metals have already been used for therapeutic purposes. In view of the use” they are put to, such products should e quite easily soluble in alkali, because in such case only their absorption in the intestinal alkaline juice is assured.
  • the metal heretofore meet these requirements not at all, or only partially.
  • casein 1s for instance dissolved in alkali and the alkaline solution treated with sodium phosphate and solutions of metal salts.
  • Another processalready known describes in a similar manner the manufacture of tricalcium phosphate albumin compounds.
  • the pyrophosphate 10 which comprises metal pyrophosphate casein compounds colloidally soluble in dilute alkaline solutions, which are entirely soluble in alkali; the solutions of this'compound in sodium bicareonate and diluted solutions of sodium car- 4 leonate are stable.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Description

I phosphoric acid albumm compounds known th UNITED sures PATENT OFFICE.
ALBERT FREY, BASEL, SWITZERLAND CHEMICAL WORKS, 013
,ASSIGNOR TO THE HOFFMANN-LA ROCHE NEW YORK, N. Y., A CORPORATION OF NEW YORK.
Be it known that I, ALBERT FREY, a citizen of Switzerland, and a resident of Basel, zerland, have invented certain new and useful Improvements in Processes for the Manufacture of Metal Pyrophosphate Casein Compounds Colloidally Soluble in Dilute Alkaline Solutions, of which the following tak 1s a specification. U I E y invention relates to a new process for the manufacture of metal pyrophosphate casein compounds colloidally soluble in dilute alkaline solutions, which consists in dis solving casein in alkali pyrophosphate and adding another metal salt to this solution. Compounds which contain albumin, phosphoric acid and metals have already been used for therapeutic purposes. In view of the use" they are put to, such products should e quite easily soluble in alkali, because in such case only their absorption in the intestinal alkaline juice is assured. The metal heretofore meet these requirements not at all, or only partially. v
According to the processes known heretofore relating to the manufacture of metal phosphoric acid albumin compounds, casein 1s for instance dissolved in alkali and the alkaline solution treated with sodium phosphate and solutions of metal salts. In one instance it has been proposed to completely saturate the acid valences of casein by taking it up in an excess of alkali or alkaline earth, and to combine the metaphosphoric acid with the albumin molecule by adding metaphosphoric acid to the alkaline solu-, tion. Another processalready known describes in a similar manner the manufacture of tricalcium phosphate albumin compounds.
disadvantage products which are not soluble 0th these of yielding in alkali. In-order processes have the to render the products more easily soluble in alkali, it has been recommended touse greatly diluted solutions, but this is unfavorable in practice. It has further been proposed to use pyrophosphoric acid and its salts for the manufacture 0 calciumand iron-phosphoric acid al-' bumin compounds, soluble in alkali; here solubility Specification of Letters Patent.
' poses.
, tion of 112 ,cipitated by adding alcoho Patented June 14, 1921.
have the disadvantage of containing little phosphoric acid, which no doubt is to the addition of free alkali when combi11- mg the phosphoric acid with the albumin molecule. In the new process, casein, without havmg previously been dissolved in alkali, is
en up in a solution of alkali pyrophosphate and another metal salt added to the solution. The resulting product meets all requlrements. By the simpl solving in alkali pyro nation of phosphoric he mixture shows an acid reaction after the addition of the metal salt, by which fact the transformation distinguishes itself from the processes known heretofore, which latter erlrliploy an alkaline solution. P
e metal Ewample I.
. 66 parts of casein are dissolved in a soluparts of crystallized sodium pyrophosphate and 800 parts of water and, while stirring, 156 parts of a four times normal solution of calcium chlorid are added to the mixture. The new compound is pre- After having C. The prodpyrophosphate its solutions in sodium bicarbonate and dilgfedsolution of sodium carbonate are sta e.
been washed it is dried at Example 2.
6.6 parts of casein are dissolved in a solution of 11.2 parts of sodium and 120 parts of water and to this 19.5 arts of a 23% solution of ferric-chlorid are a ded, w 'le stirring. he compound obtained is precipitated with alcohol, washed and dried at 50 C It contains 50% of ferricphosphate. The product is easily soluble in alkali; the solutions are stable.
claim: 1. As a new article of manufacture the pyrophosphate 10 which comprises metal pyrophosphate casein compounds colloidally soluble in dilute alkaline solutions, which are entirely soluble in alkali; the solutions of this'compound in sodium bicareonate and diluted solutions of sodium car- 4 leonate are stable.
2. llhe process for the manufacture of metal pyrophosphate casein compounds colloidally soluble in dilute alkaline solutions dissolving casein in alkali v memes pyrophosphate adding a metal salt to this solution and precipitating the compound thus produced.
In witness whereof I have hereunto set my hand.
ALBERTFREY;
Witnesses Harmon Knnm, HUBERT Ramon.
US367465A 1920-03-20 1920-03-20 Process for the manufacture of metal pyrophosphate casein compounds colloidally soluble in dilute alkaline solutions Expired - Lifetime US1381295A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US367465A US1381295A (en) 1920-03-20 1920-03-20 Process for the manufacture of metal pyrophosphate casein compounds colloidally soluble in dilute alkaline solutions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US367465A US1381295A (en) 1920-03-20 1920-03-20 Process for the manufacture of metal pyrophosphate casein compounds colloidally soluble in dilute alkaline solutions

Publications (1)

Publication Number Publication Date
US1381295A true US1381295A (en) 1921-06-14

Family

ID=23447290

Family Applications (1)

Application Number Title Priority Date Filing Date
US367465A Expired - Lifetime US1381295A (en) 1920-03-20 1920-03-20 Process for the manufacture of metal pyrophosphate casein compounds colloidally soluble in dilute alkaline solutions

Country Status (1)

Country Link
US (1) US1381295A (en)

Similar Documents

Publication Publication Date Title
US1381295A (en) Process for the manufacture of metal pyrophosphate casein compounds colloidally soluble in dilute alkaline solutions
US1447501A (en) Process for the preparation of basic salicylate of aluminum
US3488702A (en) Production of inorganic fluoro-chemicals and silicon dioxide
US1994002A (en) Zinc 2.4.5-trichlorophenolate
US3358025A (en) Process of recovering 4, 4'-methylenedi
US3557198A (en) Process for the production of alkali metal salicylates
US2117777A (en) Double salts of calcium ascorbate with calcium salts of other polyhydroxy-mono-carboxylic acids and process of making them
US393388A (en) Mayer
US1149712A (en) Method for the manufacture of salts of formaldehyde-sulfurous acid with aluminium oxid.
US2938032A (en) pasotted jx
US2191820A (en) Process for the preparation of 2-nitronaphthalene-4, 8-disulphonic acid
US1338364A (en) Process of making 2-aminoanthraquinone
US1609038A (en) Process of preparing magnesium cyanide and product thereof
US2321958A (en) Formaldehyde addition products and their preparation
US1455264A (en) Eenst preiswebk
US852372A (en) Method of producing dicalcium phosphate.
US1893248A (en) Manufacture of mercuri-mononitro-para-cresol and its salts
US1052762A (en) Pharmaceutical product.
US2845426A (en) Chr-chj
US2267971A (en) Process of producing glutamic acid
US1703755A (en) Oxidation of aldoses
US2497063A (en) Process for the production of alkali metal phytates
US1964734A (en) Crystalline magnesium xylonate and process for the preparation of magnesium salts of aldonic acids
US3355485A (en) Preparation of sodium cyclohexyl sulfamate free of sulfate ions
US2111756A (en) Manufacture of naphthostyril and 8-amino-1-naphthoic acid